Skip to main content
Account

Table 1 Characteristics of the study population according to sex

From: Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017

 

M

F

RR (95% CI)

N

(%)

N

(%)

Total

16,547

37.3

27,871

62.7

 

Age in years (mean)

48.81

 

51.53

  

Age groups

  < 31

2466

14.9

3585

12.9

1.15 (1.10–1.22)

 31–60

10,396

62.8

16,019

57.5

1.09 (1.08–1.11)

 61–90

3661

22.1

8197

29.4

0.75 (0.73–0.78)

  > 91

24

0.1

70

0.3

0.58 (0.36–0.92)

Diagnosis

 Mild depression

236

1.4

314

1.1

1.27 (1.07–1.50)

 Moderate depression

4543

27.5

7773

27.9

0.98 (0.95–1.02)

 Severe depression

9636

58.2

16,326

58.6

0.99 (0.98–1.01)

 Severe depression with psychosis

2132

12.9

3458

12.4

1.04 (0.99–1.09)

 Pat. receiving any psychotropic drugs

15,764

95.3

26,799

96.2

0.99 (0.99–0.99)

 N psychotropic drugs (mean)

2.60

 

2.68

  

N psychotropic drugs

 0

783

4.7

1072

3.8

1.23 (1.12–1.35)

 1

3553

21.5

5527

19.8

1.08 (1.04–1.12)

 2

4923

29.8

8246

29.6

1.00 (0.98–1.03)

 3

3847

23.2

6690

24.0

0.97 (0.94–1.00)

 4 + 

3441

20.8

6336

22.7

0.91 (0.88–0.95)

  1. N number, M males, F females, df degrees of freedom, pat. patients, RR relative risk, 95% CI 95% confidence interval